Office of Technology Management
The Office of Technology Management (OTM) facilitates the translation of MBICR research from bench to bedside for public benefit. We foster MBICR researchers in exploring the entrepreneurial potential of their discoveries by providing education and resources. We file both the US and PCT patent application for intellectual property generated by MBICR employees. We catalyze relationships with industrial partners to bring our scientific breakthroughs to the market. Two law firms in the US routinely assist the office in conducting various tasks listed at below.
MBICR offers a variety of licenses and agreements to handle the transfer of our technologies to the marketplace.
Material Transfer Agreement (MTA)
MTAs govern the transfer of research material both into and out of MBICR. An MTA is needed any time when an MBICR investigator sends out research material to another institution or receives research material from another institution. Examples of such research material include physical materials such as tissue samples, transgenic mice, cell lines, gene constructs, compounds, and antibodies, as well as computer software and data. Incoming MTAs govern the transfer of material from an outside institution into MBICR, whereas outgoing MTAs oversee the transfer of research materials developed or collected at MBICR to an outside institution.
Confidentiality agreements (CDAs), also known as Non-Disclosure Agreements (NDAs), are used to protect proprietary information that is disclosed during the process of evaluating a possible research or business collaboration. CDAs protect MBICR and its researchers in at least three ways.
Industry sponsors will often ask MBICR to sign a CDA before proceeding to discuss a sponsor-initiated research project. If you have received a CDA from an external institution, please forward the MTA to the OTM.
IP Protection and Commercialization Plan
The Office of Technology Management evaluates the patentability and commercial value of inventions created by MBICR employees. Our team will work closely with you to assess new technologies, guide you on optimal strategies that support commercialization of your idea, and devise a tailored commercialization and IP protection plan. If a favorite assessment is reached, the office usually submits a US provisional patent application followed by filing a US non-provisional patent application and a PCT application within one year to acclaim the priority date of the provisional patent application. Licensing the technology to an external partner for further development or spinning off a startup company are two of many possible options that the office is striving to achieve. If you have an invention or technology that you think is new, exciting and has potential as a commercial product or application, please disclose it to our office.
Public Disclosure?A public disclosure occurs when you discuss your invention to anyone outside MBICR in enough detail that the audience can understand and replicate your idea or invention. Public disclosures often happen in poster sessions, public talks or presentations, social conversations, and website postings.
Public Use?Public use describes a situation in which your invention becomes accessible to the public in any way that does not represent experimental use. An example is the use of a pharmaceutical therapy to treat patients in a clinical setting that is not part of a research study.
Offer for Sale?An offer for sale action happens when an invention is offered to a buyer in exchange for compensation or the promise of compensation. This is called an on-sale bar to patentability.?Inventors need to be aware that offers to sell potentially patentable inventions, even if made under a nondisclosure agreement, even if no sales are ever made, and even if only for a single product, can start the one-year grace period within which a patent application must be filed in the United States.
MBICR partners with industry for basic research and product development in two ways.